McDermott and Bull executive Search
 

Other News

Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)

VILLEPINTE, France, April 24, 2026 /PRNewswire/ — GUERBET (FR0000032526 GBT): Guerbet, a global leader in medical imaging, announces a positive outcome from a worksharing procedure, involving several EU member states, for a new Lipiodol® indication in interventional radiology procedures…

Anaxiom Announces Early Clinical Results from First-in-Human Experience of Novel Minimally Invasive Obesity Device; Advances Toward U.S. Early Feasibility Study

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Anaxiom Corporation, a clinical-stage medical device company developing a novel, non-surgical treatment for obesity, today announced the successful completion of a 12-patient OUS clinical study. Early results demonstrate device safety and promising weight loss supporting advancement toward a U.S. Early Feasibility Study. Promising Early Clinical Experience The […]

NEW STUDY LINKS GLP-1 MEDICATIONS TO LOWER RISK OF ATRIAL FIBRILLATION, INDEPENDENT OF WEIGHT LOSS

CHICAGO, IL, APRIL 23, 2026 – A new study analyzing data from more than 13,000 patients found that people using the increasingly popular weight-loss drugs known as GLP-1 receptor agonists (GLP-1-RAs) have a reduced risk of atrial fibrillation (AF), even after accounting for the medications’ effects on weight loss and overall […]

Late-Breaking Data from PRESERVE Trial Evaluates XVIVO’s HOPE Preservation Approach in Heart Transplantation

Preliminary results suggest potential to support extended preservation time and donor heart utilization TORONTO–(BUSINESS WIRE)–XVIVO, a global medtech company in the organ transplant industry, today announced late-breaking preliminary data from the PRESERVE Trial (NCT05881278) evaluating hypothermic oxygenated perfusion (HOPE) using the XVIVO Heart Assist Transport™. The trial met its pre-specified […]

APPLE WATCH CAPTURES MORE PEDIATRIC ARRHYTHMIA EVENTS THAN TRADITIONAL PATCH MONITORS

CHICAGO, IL, APRIL 25, 2026 – A new study examining the accuracy of wearable technologies for capturing irregular heartbeats in children found that the Apple Watchâ can capture arrhythmia events potentially more effectively than traditional ambulatory patch rhythm monitors. Researchers presented these findings as an oral abstract today at Heart Rhythm 2026. Arrhythmias occur […]

FLEX Vascular Announces 12-Month Real-World Outcomes Demonstrating Strong Safety, Durability, and Reduced Reinterventions with FLEX™ Vessel Prep System

LONDON, April 23, 2026 /PRNewswire/ — Minneapolis-based FLEX Vascular announced the presentation of 12-month results from the FLEX FIRST AV Registry, a prospective, multi-center, real-world study evaluating the FLEX™ Vessel Prep System in patients with dysfunctional hemodialysis access….

NorthStar Mapping System Now Commercially Available in the United States

MINNEAPOLIS–(BUSINESS WIRE)– #WeareiMR–Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce the U.S. commercial launch of its NorthStar® Mapping System. As the first and only cardiac mapping and guidance system designed specifically to harness the power of magnetic resonance (MR) imaging to see the heart throughout a minimally-invasive interventional procedure, NorthStar brings the field of interventional MR (iMR) to life. NorthStar provides physicians with an entirely ne